News | Ablation Systems | May 21, 2018

First Human Cases Treated With Globe Multi-electrode Contact Mapping and Ablation System

Study at Heart Rhythm 2018 shows very good efficacy in treating atrial fibrillation

The Kardium Globe combined mapping and ablation catheter. The device has a distal multi-electrode array consisting of 16 ribs with 122 gold-plated electrodes. Ablation can be done with up to 24 electrodes simultaneously.  #HRS2018

May 21, 2018 — Complete pulmonary vein isolation (PVI) was achieved in more than 99 percent of patients in a first-in-man study using the Kardia Globe multi-electrode array catheter ablation system. The late-breaking study was presented at Heart Rhythm 2018, the Heart Rhythm Society’s 39th Annual Scientific Sessions.

The Kardium Globe Mapping and Ablation System is a complete, combined system intended to assist in the diagnosis and treatment of atrial fibrillation (AF). A big question for technological advancement of Afib catheter ablation has been whether the creative new concept of a diagnostic mapping options of single-tip and basket catheters combined with the simplicity of using balloon catheters for ablation would work to quickly and accurately to isolate the pulmonary veins.

Authors of the study said the new device offers a easy handling and fast single-shot pulmonary vein isolation (PVI). It continuously updates several mapping types (e.g. voltage mapping, activation mapping) from all 122 electrodes on the device in real-time during ablation, This feature  demonstrated in study a unique capability to go beyond PVI for substrate description plus ablation, and for rotor mapping plus rotor ablation with a single catheter.

The Globe device has a distal multi-electrode array consisting of 16 ribs with 122 gold-plated electrodes. It was used prospectively in 60 patients (mean age 64±10 years, 58 patients with paroxysmal AF) in two centers (Hirslanden Hospital, Zurich and Heart Center, Leipzig). Each electrode can record electrograms, ablate, pace and can measure tissue contact, temperature, and current. Ablation can be done with up to 24 electrodes simultaneously. The amount of current delivered to each electrode to maintain the target electrode temperature (57-65°C) is automatically controlled. 

Immediate automatic down regulation of power is provided in case of intermittent loss of contact from such causes as deep breath.

The study's first six and 12-month follow-up data show complete PVI) was achieved in 234/236 veins (99.2 percent) of patients. Procedure time and fluoroscopy time measured 147±45 and 11±4 minutes, respectively. In two patients, cardiac tamponade was observed (3 percent), and no cases of stroke, PV stenosis, esophageal perforation or phrenic nerve paresis were observed.

Find links to all the Heart Rhythm 2018 Late-breaking Studies

Related Content

News | Ablation Systems

April 5, 2021 — Acutus Medical today announced initial U.S. enrollments in the company’s AcQForce Flutter ...

Home April 05, 2021
Home
News | Ablation Systems

June 16, 2020 – The Montreal Heart Institute (MHI) and Thermedical, a developer of thermal-ablation systems to treat ...

Home June 16, 2020
Home
News | Ablation Systems

May 8, 2020 – Results from a first-in-human early feasibility study (EFS) using a saline enhanced radiofrequency (SERF) ...

Home May 08, 2020
Home
Feature | Ablation Systems

May 8, 2020 — A new clinical trial effectively uses pulsed field (PF) energy to treat patients with persistent or ...

Home May 08, 2020
Home
Videos | Ablation Systems

Clifford Robinson, M.D., associate professor of radiation oncology, chief of the SBRT service, director of clinical ...

Home September 26, 2019
Home
News | Ablation Systems

September 17, 2019 — Treating high-risk heart patients with a single, high dose of radiation therapy can dramatically ...

Home September 17, 2019
Home
News | Ablation Systems

May 16, 2019 — Johnson & Johnson Medical Devices Companies announced that Biosense Webster, Inc.’s QDot Micro catheter ...

Home May 16, 2019
Home
News | Ablation Systems

May 16, 2019 — CardioFocus Inc. announced the presentation of results from its pivotal confirmatory study evaluating the ...

Home May 16, 2019
Home
News | Ablation Systems

May 14, 2019 — The Heart Rhythm Society (HRS) in partnership with three other professional societies issued an ...

Home May 14, 2019
Home
News | Ablation Systems

May 13, 2019 — Imricor announced the signing of a commercial agreement with the Haga Hospital in The Hague, Netherlands ...

Home May 13, 2019
Home
Subscribe Now